Molecular Basis of Signaling Specificity of Insulin and IGF Receptors: Neglected Corners and Recent Advances
Open Access
- 1 January 2012
- journal article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 3, 34
- https://doi.org/10.3389/fendo.2012.00034
Abstract
Insulin and insulin-like growth factor (IGF) receptors utilize common phosphoinositide 3-kinase/Akt and Ras/extracellular signal-regulated kinase signaling pathways to mediate a broad spectrum of “metabolic” and “mitogenic” responses. Specificity of insulin and IGF action in vivo must in part reflect expression of receptors and responsive pathways in different tissues but it is widely assumed that it is also determined by the ligand binding and signaling mechanisms of the receptors. This review focuses on receptor-proximal events in insulin/IGF signaling and examines their contribution to specificity of downstream responses. Insulin and IGF receptors may differ subtly in the efficiency with which they recruit their major substrates (IRS-1 and IRS-2 and Shc) and this could influence effectiveness of signaling to “metabolic” and “mitogenic” responses. Other substrates (Grb2-associated binder, downstream of kinases, SH2Bs, Crk), scaffolds (RACK1, β-arrestins, cytohesins), and pathways (non-receptor tyrosine kinases, phosphoinositide kinases, reactive oxygen species) have been less widely studied. Some of these components appear to be specifically involved in “metabolic” or “mitogenic” signaling but it has not been shown that this reflects receptor-preferential interaction. Very few receptor-specific interactions have been characterized, and their roles in signaling are unclear. Signaling specificity might also be imparted by differences in intracellular trafficking or feedback regulation of receptors, but few studies have directly addressed this possibility. Although published data are not wholly conclusive, no evidence has yet emerged for signaling mechanisms that are specifically engaged by insulin receptors but not IGF receptors or vice versa, and there is only limited evidence for differential activation of signaling mechanisms that are common to both receptors. Cellular context, rather than intrinsic receptor activity, therefore appears to be the major determinant of whether responses to insulin and IGFs are perceived as “metabolic” or “mitogenic.”Keywords
This publication has 97 references indexed in Scilit:
- Requirement for Protein-tyrosine Phosphatase SHP-2 in Insulin-induced Activation of c-Jun NH2-terminal KinaseOnline Journal of Public Health Informatics, 2000
- PSM, a mediator of PDGF-BB-, IGF-I-, and insulin-stimulated mitogenesisOncogene, 2000
- Dynamics of Insulin Signaling in 3T3-L1 AdipocytesOnline Journal of Public Health Informatics, 1998
- Insulin-like Growth Factor-I Receptor Internalization Regulates Signaling via the Shc/Mitogen-activated Protein Kinase Pathway, but Not the Insulin Receptor Substrate-1 PathwayOnline Journal of Public Health Informatics, 1998
- The Tyrosine Residue at 1250 of the Insulin-like Growth Factor I Receptor Is Required for Ligand-Mediated InternalizationBiochemical and Biophysical Research Communications, 1997
- Regulation of cell surface GLUT1, GLUT3, and GLUT4 by insulin and IGF‐I in L6 myotubesFEBS Letters, 1995
- Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathwayCell, 1994
- Distinct .alpha.-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activitiesBiochemistry, 1992
- The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kineticsBiochemical and Biophysical Research Communications, 1991
- Insulin binding sites on the nuclear envelope: potential relationship to mRNA metabolismJournal of Cellular Biochemistry, 1982